Concepedia
Statistics
Publications
6
Citations
344
H-Index
Active since
2014
Affiliations
University of Colorado Denver(Current)
Moffitt Cancer Center
University of South Florida
University of Colorado Cancer Center
Katie M. Mishall is an author at University of Colorado Denver specializing in molecular biology, molecular oncology, and cell signaling.
Publications per year
2014–2018
Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells
Wade M. Borcherds, François‐Xavier Theillet, Andrea Katzer et al. · Nature Chemical Biology · 2014 · 192 citations
Life Sciences, Cell Biology, Molecular Biology +12
Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling
Sarah K. Nelson-Taylor, Anh T. Le, Minjae Yoo et al. · Molecular Cancer Therapeutics · 2017 · 81 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
Thomas C. Beadnell, Katie M. Mishall, Qiong Zhou et al. · Molecular Cancer Therapeutics · 2016 · 23 citations · Full text
Medicine, Molecular Biology, Oncology +17
Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis
Brittelle E. Kessler, Katie M. Mishall, M. Kellett et al. · Oncogene · 2018 · 20 citations
Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides
Bin Fang, Melissa Hoffman, Abu‐Sayeef Mirza et al. · Methods · 2015 · 16 citations
Life Sciences, Biochemistry, Molecular Biology +14
1–5 of 6